Market News
FDA Commissioner Defends Tough Drug Approval Stance Amid Growing Criticism
The FDA just rejected a promising melanoma treatment from Replimune, sparking fury in the biotech world. Commissioner Marty Makary explains...
06/05/2026
2 views